BBHC
IHE icon

Brown Brothers Harriman & Co’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Brown Brothers Harriman & Co’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-675
Closed -$44.8K – 1449
2024
Q2 		$44.8K Hold
675
– – ﹤0.01% 784
2024
Q1 		$45.8K Hold
675
– – ﹤0.01% 775
2023
Q4 		$41.7K Hold
675
– – ﹤0.01% 750
2023
Q3 		$39.8K Buy
+675
New +$41.4K ﹤0.01% 740

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RW
Rockport Wealth Fairview Park, Ohio $549M AUM 22.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Brown Brothers Harriman & Co's IHE Position: Q3 2024 in Review

Brown Brothers Harriman & Co sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2024, closing a stake of 675 shares — an estimated $44.8K sold.

Brown Brothers Harriman & Co first reported a position in IHE in Q3 2023 and held it in 4 quarters. The position peaked at $45.8K in Q1 2024. 143 funds tracked by Wall St. Rank hold IHE as of Q3 2024.

  • Brown Brothers Harriman & Co reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2024 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 675 iShares US Pharmaceuticals ETF shares in Q3 2024, an estimated $44.8K.
  • Brown Brothers Harriman & Co first reported a position in iShares US Pharmaceuticals ETF in Q3 2023 and held it in 4 quarters.
  • Brown Brothers Harriman & Co's iShares US Pharmaceuticals ETF position peaked at $45.8K in Q1 2024.
  • 143 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2024.

Based on Brown Brothers Harriman & Co's 13F filing for Q3 2024, filed 13 Nov 2024.